Crystal Hilger
Mayo Clinic(US)WinnMed(US)
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, Chemotherapy-related skin toxicity, Cancer Immunotherapy and Biomarkers, Cancer-related Molecular Pathways, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study(2017)132 cited
- → A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer(2019)77 cited
- → Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy(2014)49 cited
- → Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer(2017)37 cited
- → An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy(2014)32 cited
- → Optimizing Lenvatinib Therapy in Patients with Metastatic Radioactive Iodine-resistant Differentiated Thyroid Cancers(2017)27 cited
- → Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma(2020)24 cited
- → Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers(2023)22 cited
- → Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy(2020)16 cited
- → Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas(2022)12 cited